Select Medical Holdings (SEM) Cash & Equivalents (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Cash & Equivalents data on file, last reported at $25.7 million in Q1 2026.

• Quarterly Cash & Equivalents fell 51.74% year-over-year to $25.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.7 million (down 51.74% YoY) and the FY2025 annual result came in at $26.5 million, down 55.57% from the prior year.
• Cash & Equivalents retreated to $25.7 million in Q1 2026 per SEM's latest filing, from $26.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $191.5 million in Q3 2024 and bottomed at $25.7 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $83.7 million (2023), against an average of $83.5 million.
• The widest annual swing landed in 2022, when Cash & Equivalents tumbled 88.22%; it then soared 147.25% in 2024.
• Tracing SEM's Cash & Equivalents over 5 years: stood at $97.9 million in 2022, then sank by 46.24% to $52.6 million in 2023, then climbed by 13.42% to $59.7 million in 2024, then plunged by 55.57% to $26.5 million in 2025, then dropped by 3.17% to $25.7 million in 2026.
• Per Business Quant, the three latest SEM Cash & Equivalents figures stand at $25.7 million (Q1 2026), $26.5 million (Q4 2025), and $60.1 million (Q3 2025).

Peer Comparison